If you would like to submit a blog post for consideration, please email firstname.lastname@example.org
In this month’s webinar with our CEO Paul Elmslie, we introduced strategies on how to manage your clinical team to deliver the best support to you and your patients.
What is the secret to a well-run practice that delights patients? Efficient clinical support staff are crucial in facilitating your work and maximising productivity in a fast-paced general practice. But how do you best utilise and optimise your team from the front desk, to the nursing team, to the practice manager?
To submit topic suggestions for the next webinar, please click here. Continue reading “[WEBINAR]: How to maximise the performance of your clinical team”
People with acne have a significantly increased risk of developing major depression, but only in the first five years after diagnosis, according to a study recently published in the British Journal of Dermatology.
Canadian researchers conducted an analysis of nearly two million people and found that people with acne are at greatest risk for major depression within a year of their diagnosis. Their risk of suffering from major depression during this time is 63 per cent higher than for people who do not suffer from the skin condition. Continue reading “Acne Patients at Significantly Higher Risk of Major Depression”
In this month’s webinar with our CEO Paul Elmslie, we introduced strategies on how to move from bulk-billing to private billing.
With Medicare rebates remaining low, how do you meet the increasing cost of providing medical care in your practice? Doctors are forced to take a pay-cut, see more patients, or charge more. Most GPs will be unable to afford the first two options if they wish to continue to provide safe, efficient care to their patients and avoid burnout. If you are currently bulk-billing all or a large proportion of your patients, you may need to introduce or increase out-of-pocket expenses to ensure the sustainability of your practice.
To submit topic suggestions for the next webinar, please click here.
Standard sunscreen application does not provide effective body coverage, leaving 11 percent of the body exposed to UV radiation, according to new research.
A study recently published in the International Journal of Cosmetic Science assessed sunscreen application habits and relative body coverage after single whole-body application.
Fifty-two volunteers were asked to follow their usual sunscreen application routine. Standardised UV photographs were conducted before and immediately after product application to evaluate relative body coverage. Continue reading “Standard Sunscreen Application Leaves Skin Uncovered”
Are vitamin D supplements an effective treatment for psoriasis in older patients?
Vitamin D deficiency does not cause psoriasis, but it may impair the body’s ability to keep skin healthy. Vitamin D deficiency is quite common in people with chronic plaque psoriasis.
A recent study published in the Journal of Dermatological Treatment investigated the clinical effects of vitamin D supplements on psoriasis patients aged 50 to 84 years. Continue reading “Are vitamin D supplements an effective treatment for psoriasis?”
Biologic therapy is effective for treatment of moderate-to-severe psoriasis but may be associated with an increased risk for serious infection.
A recent study looked at the serious infection rate among psoriasis patients treated with biologic, as compared with non-biologic systemic agents.
Researchers identified 5,889 adult psoriasis patients who had been treated with systemic therapies. Continue reading “Biologic Therapy for Psoriasis Carry Serious Infection Risk”
How does topical corticosteroid phobia affect treatment adherence in patients with atopic dermatitis?
Topical corticosteroid phobia refers to the negative feelings and beliefs related to topical corticosteroids experienced by patients and their caregivers.
This phenomenon may be a major contributing factor in treatment failure in patients with atopic dermatitis, yet is sparsely described in literature. Continue reading “Topical Corticosteroid Phobia in Atopic Dermatitis Patients”
At the recent European Academy of Dermatology and Venereology Congress in Geneva, new evidence was delivered in the management of atopic dermatitis. This included presentations on the effectiveness of antibody-based therapies and the development of new drugs to treat the condition.
Professor Tilo Biedermann classified antibody-based therapies for atopic dermatitis into three groups: not effective, no data, and some data. Continue reading “New Developments in Atopic Dermatitis”
An Italian study has investigated the effectiveness, tolerability and reasons for discontinuation of etanercept in a real-life cohort of children and adolescents with moderate to severe plaque psoriasis.
Etanercept is a biopharmaceutical that treats autoimmune diseases by acting as a tumour necrosis factor inhibitor. It is licensed for the treatment of moderate to severe plaque psoriasis in children. Continue reading “Managing Psoriasis with Etanercept”
Patient education about the importance of controlling inflammation is vital to effectively managing psoriatic arthritis, according to a review published in the New England Journal of Medicine.
The review discusses the epidemiological and clinical features, pathophysical characteristics, and available pharmacotherapies for psoriatic arthritis.
Psoriatic arthritis occurs in up to 30 percent of people with psoriasis and can have serious debilitating effects on the peripheral joints, spine, tendon insertions, and fingers. Management has improved, but complete disease control is not yet achievable. Continue reading “Managing Psoriatic Arthritis”